A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder

By Munizza C.   Olivieri L.   Di Loreto G.   Dionisio P.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1703-1713

Informa Healthcare

Access to resources Recommend Favorite

Comparative efficacy and tolerability of two sustained-release formulations of diclofenac: results of a double-blind, randomised study in patients with osteoarthritis and a reappraisal of diclofenac's use in this patient population

By Wagenitz Andreas   Mueller Edgar A.   Frentzel Adrian   Cambon Nathalie  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1957-1966

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

By Pigott Teresa A.   Prakash Apurva   Arnold Lesley M.   Aaronson Scott T.   Mallinckrodt Craig H.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1303-1318

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

By Colonna Lucien   Andersen Henning Friis   Reines Elin Heldbo  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1659-1668

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

By Wade A.   Gembert K.   Florea I.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1605-1614

Informa Healthcare

Access to resources Recommend Favorite